Back to BlackRock, Inc. BlackRock, Inc.

ADPTADPT
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in Adaptive Biotechnologies Corp.

BlackRock, Inc. holds 15.1M shares of ADPT (Adaptive Biotechnologies Corp.), worth $324.7M as of 2026-Q2. The position was increased (+13.8% shares). ADPT represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$324.7M

Current Shares

15.1M

Total Value Change

+$252.1M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
15.1M
+13.8%
$324.7M0.0%$21.45
35
2026-Q1
Decreased
13.3M
-0.2%
$184.6M0.0%$16.08
0
2025-Q4
Decreased
13.3M
-0.2%
$216.5M0.0%$16.42
0
2025-Q3
Decreased
13.4M
-2.3%
$199.8M0.0%$13.46
0
2025-Q2
Increased
13.7M
+11.8%
$159.2M0.0%$11.79
34
2025-Q1
Increased
12.2M
+0.9%
$90.9M0.0%$7.67
30
2024-Q4
New
12.1M
-
$72.7M0.0%$6.11
41

Other major holders of ADPT: VIKING GLOBAL INVESTORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used